Document is current
Any future updates will be listed below
-
Authors
Troester, Selina https://orcid.org/0000-0001-6268-4442
Eder, Thomas https://orcid.org/0000-0002-0932-2052
Wukowits, Nadja
Piontek, Martin
Fernández-Pernas, Pablo
Schmoellerl, Johannes https://orcid.org/0000-0002-8461-8881
Haladik, Ben https://orcid.org/0000-0001-6903-7379
Manhart, Gabriele
Allram, Melanie
Maurer-Granofszky, Margarita https://orcid.org/0000-0003-3519-9972
Scheidegger, Nastassja https://orcid.org/0000-0002-3091-2970
Nebral, Karin https://orcid.org/0000-0002-0548-541X
Superti-Furga, Giulio https://orcid.org/0000-0002-0570-1768
Meisel, Roland
Bornhauser, Beat https://orcid.org/0000-0003-2890-3191
Valent, Peter https://orcid.org/0000-0003-0456-5095
Dworzak, Michael N.
Zuber, Johannes https://orcid.org/0000-0001-8810-6835
Boztug, Kaan
Grebien, Florian https://orcid.org/0000-0003-4289-2281
-
Funding
Funding for this research was provided by:
Austrian Science Fund (P35628, P35298, TAI490)
- License Information
-
More Information
Article History
Received: 6 March 2024
Accepted: 8 May 2025
First Online: 19 May 2025
Competing interests
: J.Z. is a founder, shareholder, and scientific advisor of Quantro Therapeutics GmbH. J.Z. and the Zuber laboratory receive research support and funding from Boehringer Ingelheim. P.V. received consultancy honoraria from Pfizer, AOP Orphan, Delbert, Novartis, and Blueprint. The other authors declare no conflict of interest.
